Fennec Pharmaceuticals Inc. financial data

Symbol
FENC on Nasdaq
Location
Po Box 13628, 68 Tw Alexander Drive, Research Triangle Park, NC
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Former names
ADHEREX TECHNOLOGIES INC (to 8/14/2014)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 610 % -4.49%
Debt-to-equity -51.8K % -7446%
Return On Equity -2.85K % -553%
Return On Assets 6.11 %
Operating Margin 12 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.4M shares +3%
Common Stock, Shares, Outstanding 27.3M shares +3.09%
Entity Public Float 138M USD +40.4%
Common Stock, Value, Issued 145M USD +1.35%
Weighted Average Number of Shares Outstanding, Basic 27.3M shares +3.17%
Weighted Average Number of Shares Outstanding, Diluted 27.3M shares +3.17%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 48.9M USD +118%
Research and Development Expense 204K USD -79.1%
Selling and Marketing Expense 17.1M USD +99.7%
General and Administrative Expense 23.5M USD +9.11%
Operating Income (Loss) 5.87M USD -7.99%
Nonoperating Income (Expense) -3.13M USD -26.8%
Net Income (Loss) Attributable to Parent 2.74M USD -2%
Earnings Per Share, Basic 0.05 USD/shares +4.76%
Earnings Per Share, Diluted 0.05 USD/shares +4.76%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 43.1M USD +188%
Other Assets, Current 283K USD +784%
Assets, Current 62.2M USD +222%
Operating Lease, Right-of-Use Asset 29K USD
Other Assets, Noncurrent 989K USD
Assets 63.2M USD +225%
Accounts Payable, Current 4.45M USD +48%
Accrued Liabilities, Current 3.04M USD +293%
Contract with Customer, Liability, Current 252K USD
Liabilities, Current 7.75M USD +105%
Contract with Customer, Liability, Noncurrent 25M USD
Operating Lease, Liability, Noncurrent 2K USD
Liabilities 64.5M USD +121%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.24M USD 0%
Retained Earnings (Accumulated Deficit) -212M USD +1.27%
Stockholders' Equity Attributable to Parent -1.36M USD +86%
Liabilities and Equity 63.2M USD +225%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 39M USD
Net Cash Provided by (Used in) Financing Activities -1.13M USD -687%
Common Stock, Shares, Issued 27.3M shares +3.09%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 37.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 43.1M USD +188%
Deferred Tax Assets, Valuation Allowance 40.7M USD +20%
Deferred Tax Assets, Gross 40.7M USD +20%
Operating Lease, Liability, Current 12K USD
Deferred Tax Assets, Operating Loss Carryforwards 37.1M USD +23.8%
Deferred Tax Assets, Net of Valuation Allowance 26K USD 0%